Literature DB >> 12356461

Mycobacterial infection in natural killer T cell knockout mice.

I Sugawara1, H Yamada, S Mizuno, C Y Li, T Nakayama, M Taniguchi.   

Abstract

To gain a better understanding of the pathological role of natural killer (NK) T cells in murine tuberculosis, NKT knockout (KO) mice (J(alpha)281(-/-)mice) were utilized. Eight-week-old NKT KO mice of BALB/c origin and wild-type (WT) mice were infected with Mycobacterium tuberculosis Kurono strain by the airborne route using an airborne infection apparatus, and their capacity to control mycobacterial growth, granuloma formation, and cytokine production were examined. The NKT KO mice developed granulomatous lesions in the lungs; there was no statistically significant difference in pulmonary granuloma size between NKT KO and WT mice (p<0.01). The average CFU values increased 3 weeks post-infection, but decreased 9 and 11 weeks post-infection, in the lungs of NKT KO mice. When stimulated with Kurono strain in vitro, splenic cells from NKT KO mice produced less IFN-gamma than did those from WT mice. Expression of mRNA for IL-2, IL-4, IL-6, IL-10 and IL-12 p40 was slightly lower in NKT KO mice compared with WT mice. Our data indicate that NKT cells play a detrimental role in late-phase mycobacterial infection, although Th1 cells are essential in early-phase mycobacterial infection.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12356461     DOI: 10.1054/tube.2002.0331

Source DB:  PubMed          Journal:  Tuberculosis (Edinb)        ISSN: 1472-9792            Impact factor:   3.131


  24 in total

Review 1.  Role of CD1d-restricted NKT cells in microbial immunity.

Authors:  Markus Sköld; Samuel M Behar
Journal:  Infect Immun       Date:  2003-10       Impact factor: 3.441

Review 2.  V alpha14 i NKT cells are innate lymphocytes that participate in the immune response to diverse microbes.

Authors:  Yuki Kinjo; Mitchell Kronenberg
Journal:  J Clin Immunol       Date:  2005-11       Impact factor: 8.317

3.  Graft-versus-host disease in recipients of grafts from natural killer T cell-deficient (Jalpha281(-/-)) donors.

Authors:  Cynthia A Ellison; Masaru Taniguchi; Jacqie M M Fischer; Kent T Hayglass; John G Gartner
Journal:  Immunology       Date:  2006-07-26       Impact factor: 7.397

Review 4.  Evasion and subversion of antigen presentation by Mycobacterium tuberculosis.

Authors:  A Baena; S A Porcelli
Journal:  Tissue Antigens       Date:  2009-06-25

Review 5.  Early clearance of Mycobacterium tuberculosis: a new frontier in prevention.

Authors:  Ayesha J Verrall; Mihai G Netea; Bachti Alisjahbana; Philip C Hill; Reimout van Crevel
Journal:  Immunology       Date:  2014-04       Impact factor: 7.397

6.  Lower numbers of circulating Natural Killer T (NK T) cells in individuals with human T lymphotropic virus type 1 (HTLV-1) associated neurological disease.

Authors:  L C Ndhlovu; J E Snyder-Cappione; K I Carvalho; F E Leal; C P Loo; F R Bruno; A R Jha; D Devita; A M Hasenkrug; H M R Barbosa; A C Segurado; D F Nixon; E L Murphy; E G Kallas
Journal:  Clin Exp Immunol       Date:  2009-09-02       Impact factor: 4.330

7.  Mycobacterial phosphatidylinositol mannoside is a natural antigen for CD1d-restricted T cells.

Authors:  Karsten Fischer; Emmanuel Scotet; Marcus Niemeyer; Heidrun Koebernick; Jens Zerrahn; Sophie Maillet; Robert Hurwitz; Mischo Kursar; Marc Bonneville; Stefan H E Kaufmann; Ulrich E Schaible
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-08       Impact factor: 11.205

8.  Early control of Mycobacterium tuberculosis infection requires il12rb1 expression by rag1-dependent lineages.

Authors:  Halli E Miller; Richard T Robinson
Journal:  Infect Immun       Date:  2012-08-20       Impact factor: 3.441

Review 9.  The role of NKT cells in tumor immunity.

Authors:  Masaki Terabe; Jay A Berzofsky
Journal:  Adv Cancer Res       Date:  2008       Impact factor: 6.242

10.  Incorporation of NKT cell-activating glycolipids enhances immunogenicity and vaccine efficacy of Mycobacterium bovis bacillus Calmette-Guerin.

Authors:  Manjunatha M Venkataswamy; Andres Baena; Michael F Goldberg; Gabriel Bricard; Jin S Im; John Chan; Faye Reddington; Gurdyal S Besra; William R Jacobs; Steven A Porcelli
Journal:  J Immunol       Date:  2009-08-01       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.